E Marimuthu | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Dr. E. Marimuthu | Drug Discovery and Development | Best Researcher Award

Professor at Arunachal University of Studies | Ayya Nadar Janaki Ammal College | Madurai Kamaraj University | India

Dr. E. Marimuthu is a dedicated researcher and academician specializing in plant biotechnology, microbiology, and molecular biology. With over 15 years of experience in research and education, he has made significant contributions through patents, microbial sequencing, and ethnobotanical surveys. His work focuses on endangered species conservation, natural IAA production, and nanomedicine applications for cancer. Dr. Marimuthu currently serves as a Professor at Arunachal University of Studies. His multidisciplinary efforts bridge traditional knowledge with modern scientific innovations, making him a standout figure in applied life sciences and pharmaceutical biotechnology.

Publication Profile 

Scopus 

Education

Dr. Marimuthu earned his Ph.D. from Madurai Kamaraj University in 2017, focusing on the in vitro conservation of endangered tree species in the Southern Western Ghats . He completed his M.Phil. and M.Sc. from Ayya Nadar Janaki Ammal College, conducting ethnomedicinal surveys and plant growth hormone studies. His academic foundation began with a B.Sc. in Botany. Each academic milestone has been rooted in biodiversity conservation and plant-microbe interactions, establishing a strong base for his later patents and microbial gene discoveries .

Experience

Dr. Marimuthu has held various academic and research roles: Professor and Associate Professor at Arunachal University of Studies (2023–present), Assistant Professor at Sri Vidya Mandir and Vivekanandha Colleges, and Associate Scientist at Aakash Green Research Pvt. Ltd. Earlier, he served as a JRF at TBGRI, Kerala  and Technical Assistant at Kalasalingam University. His experience spans plant tissue culture, cell line work, and microbial molecular studies. With deep involvement in both lab and field research, he has nurtured innovations from concept to patent, while also mentoring students and contributing to curriculum development.

Awards 

Dr. E. Marimuthu is a prolific innovator with 8 Indian patents and 2 Canadian patents, showcasing breakthroughs in nanomedicine, cancer immunotherapy, and plant-based biotechnology . His bacterial gene sequences are submitted to NCBI, emphasizing novel microbial discoveries from unique ecological niches. Recognized nationally and internationally for his translational research, he has pioneered techniques that merge traditional plant knowledge with high-end scientific platforms. Though specific named awards are not listed, his patent record and academic promotions signify a distinguished and respected trajectory in bioscience innovation and interdisciplinary research.

Research Focus 

Dr. Marimuthu’s research emphasizes plant tissue culture, natural growth hormone production, ethnomedicinal conservation, and nanotechnology-enhanced drug delivery . He explores molecular markers for documenting genetic diversity and has successfully isolated bacterial strains producing Indole-3-acetic acid (IAA) to promote plant growth . He integrates ethnobotanical knowledge with biotechnological advancements to develop eco-friendly, scalable solutions for agriculture and medicine. His cutting-edge work in cancer-targeting mesenchymal stem cell therapy, as well as nano-immunotherapy, reflects a visionary outlook on the future of personalized medicine and sustainable pharmacology.

Publication Top Notes

Title: Chemical profiling and in silico molecular docking studies of phytochemicals from Hydnocarpus macrocarpa Warb: A GC–MS, FTIR, and physico-chemical analysis
Journal: Journal of Molecular Structure
Year: 2025

Conclusion

Dr. E. Marimuthu is an outstanding candidate for the Best Researcher Award, showcasing a rare combination of field knowledge, lab precision, patent-oriented innovation, and a commitment to both fundamental and applied science. His work contributes significantly to biotechnology, pharmacology, environmental microbiology, and regenerative agriculture.

Borros Arneth | Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Borros Arneth | Pharmacology | Best Researcher Award

Dr. Borros Arneth at Justus Liebig University Giessen and Philipps University Marburg Germany, Germany.

Dr. Borros Michael Arneth (born August 5, 1973) is a distinguished German physician and laboratory medicine expert 🧪. He studied medicine, chemistry, and biochemistry at Goethe University Frankfurt and earned his Dr. med. with research on HIV via MR spectroscopy 🧠. With board certification in Laboratory Medicine and EurClinChem recognition, he has held leading roles at TU Dresden and Giessen-Marburg University Hospital 🏥. His expertise spans neonatal screening, hematology, and molecular diagnostics 🧫. Dr. Arneth is also an editor and reviewer for top journals 📚 and a recipient of prestigious scholarships like Studienstiftung des Deutschen Volkes.

Publication Profile 

Google Scholar

Education

Dr. Borros Arneth, born on August 5, 1973, in Bad Homburg, has cultivated a remarkable academic and professional career in medicine 🧬 and chemistry ⚗️. He pursued dual studies at Johann Wolfgang Goethe University, earning his Dr. med. with a focus on HIV diagnostics via MR spectroscopy 🧠. Recognized as a European Specialist in Clinical Chemistry and Laboratory Medicine (EurClinChem) 🇪🇺, he advanced through intensive training in Frankfurt, Mainz, and Dresden. His professional scope includes neonatal screening 👶🧪, hematology 🩸, and molecular diagnostics 🔬, making him a leading voice in laboratory medicine and biomedical innovation.

Teaching Contributions

Dr. Borros Arneth has made impactful teaching contributions at Universitätsklinikum Giessen Marburg, where he serves as head of key sections 🧬🩸, including hematology, neonatal screening 👶, and molecular diagnostics 🔬. As a dedicated university lecturer (Lehrbeauftragter) 👨‍🏫, Dr. Arneth plays a vital role in shaping the future of clinical laboratory medicine. His passion for academic mentorship 🌟 and knowledge transfer has guided numerous medical students and young professionals toward excellence. Through his integrated teaching and clinical responsibilities, he continues to inspire innovation, ethical practice, and critical thinking in the next generation of laboratory physicians.

Research Focus 

Dr. Borros Arneth’s research expertise spans clinical biochemistry, immunology, and neurological disorders, with a strong emphasis on the tumor microenvironment 🧫, multiple sclerosis 🧠, and biomarker discovery in autoimmune and psychiatric diseases 🧬. His notable work includes investigations into liquid biopsies 💉, CYP2D6 pharmacogenomics 💊, and gut-brain axis communication 🌱➡️🧠. Additionally, he explores trained innate immunity 🛡️, diabetes metabolomics 🍭, and light chain analysis in CSF for CNS diseases. Through interdisciplinary integration, Dr. Arneth advances precision diagnostics and translational medicine for complex chronic and neurological conditions.

Publication Top Notes

Hui Xiao | Drug Discovery and Development | Pharmaceutical Innovation Achievement Award

Published on by Top Pharmaceutical

Hui Xiao | Drug Discovery and Development | Pharmaceutical Innovation Achievement Award

Dr Hui Xiao,regeneron,United States

Dr. Hui Xiao 🧪🔬 is a distinguished scientist specializing in biochemistry, structural biology, and mass spectrometry. With a strong focus on microtubule dynamics, protein interactions, and drug mechanisms, he has made significant contributions to understanding cellular processes. As a co-first author and lead researcher, his work has been published in esteemed journals like J. Mol. Biol., Biochemistry, and J. Biol. Chem.. His expertise spans hydrogen-deuterium exchange, proteomics, and molecular stabilization studies. Dr. Xiao’s research has advanced drug discovery, particularly in cancer therapeutics and protein biochemistry. 📚🔍 His innovative approaches continue to impact biomedical sciences globally. 🌍✨

Publication Profile

Scopus

Education

Dr. Hui Xiao 🎓 holds a Ph.D. in Analytical Chemistry from the University of Massachusetts, Amherst (2005) and a degree in Applied Chemistry from Peking University, China (1992). Currently serving as an Associate Director at Regeneron Pharmaceuticals 🏢, he specializes in protein characterization using mass spectrometry. With over a decade at Regeneron, he has progressed through roles as a Senior Staff Scientist and Staff Scientist. Previously, he held academic positions at Albert Einstein College of Medicine 🧬, advancing from Instructor to Research Associate Professor. His expertise spans analytical chemistry, protein analysis, and therapeutic protein research, making significant contributions to biomedical science. 🔬

Professional Impact

Dr. Hui Xiao 🎓 is a distinguished scientist with over 20 years of experience in academia and the biotechnology industry. Currently, he serves as an Associate Director of Analytical Chemistry at Regeneron Pharmaceuticals 🏢, a leading biotech company. His expertise lies in mass spectrometry applications for protein characterization 🔬, contributing to advancements in therapeutic development. Before joining Regeneron, Dr. Xiao held esteemed faculty positions at Albert Einstein College of Medicine 🧬, progressing from Instructor to Research Associate Professor. His extensive research and leadership have played a crucial role in bridging analytical chemistry with biopharmaceutical innovation, impacting drug discovery and development. 🚀

Scientific Contributions

Dr. Hui Xiao 🎓 is a leading expert in protein-ligand interactions, structural proteomics, and therapeutic protein analysis 🔬. His pioneering work includes the application of hydrogen-deuterium exchange mass spectrometry (HDX-MS) for epitope mapping 🧩 and microtubule stabilization research. With a deep focus on drug characterization and regulatory sciences, his contributions have significantly advanced biopharmaceutical development 💊. His expertise in mass spectrometry-driven protein analysis has helped enhance the understanding of molecular mechanisms, improving therapeutic strategies. Through innovation and research, Dr. Xiao continues to play a vital role in shaping the future of biopharmaceutical science and drug discovery. 🚀

Potential Considerations

Dr. Hui Xiao 🎓 is a renowned expert in analytical and protein chemistry, with groundbreaking work in epitope mapping and protein characterization 🔬. While his contributions significantly impact drug development, the Pharmaceutical Innovation Achievement Award 🏆 may prioritize direct advancements in drug discovery and novel pharmaceutical interventions 💊. His research has important regulatory and therapeutic implications, but highlighting specific drug innovations or regulatory breakthroughs he has led would further strengthen his case. By showcasing his role in pioneering pharmaceutical advancements, Dr. Xiao’s influence in shaping modern biopharmaceutical science can be fully recognized and appreciated. 🚀

Research Focus

Dr. Hui Xiao’s research primarily focuses on analytical chemistry 🧪, particularly in the quantitative analysis of biomolecules 🧬 using advanced mass spectrometry techniques ⚖️. His work involves CRISPR sgRNA modification analysis 🧬🔬 and the development of LC-MS-based assays for biological therapeutics 💊. He specializes in phosphorothioate isomer detection 🔄 and liquid chromatography-multiple reaction monitoring-mass spectrometry (LC-MRM-MS) 📊 for precise biomolecular quantification. His contributions are crucial in drug discovery 🏥, gene editing 🧬, and biopharmaceutical development 💉. His expertise bridges biotechnology 🔬 and analytical methodologies 📈, advancing innovations in therapeutic monitoring and molecular diagnostics 🏥.

Publication Top Notes

Quantitative Analysis of Phosphorothioate Isomers in CRISPR sgRNA at Single-Residue Resolution Using Endonuclease Digestion Coupled with Liquid Chromatography Cyclic Ion Mobility Mass Spectrometry (LC/cIMS)

Generic Enrichment Method for Liquid Chromatography-Multiple Reaction Monitoring-Mass Spectrometry Assay for Quantitative Measurement of Biological Therapeutics in Serum

Assoc Prof Dr. Djalila Boudemagh| Pharmaceutical Chemistry| Best Researcher Award-1220

Published on by Top Pharmaceutical

Assoc Prof Dr. Djalila Boudemagh,Pharmaceutical Chemistry ,Best Researcher Award

Assoc Prof Dr. Djalila Boudemagh, at Ferhat Abbas University Setif 1, Algeria

 Profile

Scopus

    

🎓Early Academic Pursuits :

Djalila Boudemagh was born on October 31, 1973, in Constantine, Algeria. Her academic journey began at the University of Mentouri Brothers Constantine 1, where she earned her Bachelor of Science (BSc) in Chemistry in 1994. She continued her studies at the same institution, receiving her Master of Science (MSc) in Material Chemistry in 2000. Her master’s thesis focused on the effect of temperature on aluminum hydroxide, magnesium hydrogen phosphate, and their mixtures. Djalila’s passion for chemistry led her to pursue a Ph.D. in material physics at Joseph Fourier University in Grenoble, France. She completed her dissertation on the synthesis and study of thermoelectric materials of the Mg2Si1-xSnx system, earning her doctorate in 2010.

🏢Professional Endeavors :

Djalila Boudemagh has dedicated over two decades to academia and research. She began her teaching career as a temporary teacher at the Chemistry Department of the University of Mentouri Brothers Constantine 1 in 1998 and later taught in the Medicine and Biology Departments until 2000. In November 2001, she joined the Department of Process Engineering at Ferhat Abbas University of Setif -1, Algeria, as an Assistant Professor. After twelve years of dedicated teaching and research, she was promoted to Associate Professor in July 2013.

In addition to her academic role, Djalila provides training and consulting services in the field of intellectual and industrial property. She has extensive experience in tutoring A-level students in various subjects, including biophysics, chemistry, the elaboration and characterization of nanoparticles, spectroscopic analysis of surfaces, and the physicochemical structure of biological macromolecules.

🔬Contributions and Research Focus :

Djalila’s research interests span a wide range of topics in chemistry and material science. Her work primarily focuses on the synthesis and application of materials and nanomaterials for health and environmental purposes, including adsorption and photocatalysis. She has made significant contributions to the field of biomaterials and composites, particularly in polymers and mineral fillers, and the extraction and isolation of bioactive molecules from plants. Her research also extends to pharmaceutical technology, water treatment, crystallization, and the development of thin films using PAPVD methods.

She has successfully supervised five Ph.D. students and twelve MSc students, guiding them through various projects related to her research interests. Djalila’s expertise in the development of nanoparticles and nanocomposites, as well as her proficiency in techniques such as sol-gel and hydrothermal methods, have established her as a prominent figure in her field.

🏅Accolades and Recognition :

In October 2019, Djalila received accreditation to direct research (HDR in Chemistry) from the Department of Chemistry at Ferhat Abbas University, Setif. This significant achievement highlights her expertise and leadership in the field of chemistry. Her research has been recognized and supported through various funded projects, including ongoing initiatives at Ferhat Abbas University Setif-1, focusing on the development of new biomaterials for tissue regeneration and environmental applications.

🌍Impact and Influence :

Djalila Boudemagh’s work has had a profound impact on both the academic and industrial sectors. Her consulting services in product development and intellectual property have benefited numerous companies, and her training programs have equipped professionals with essential skills in industrial and intellectual property. Her participation in various national and international exhibitions and fairs, such as the SIPSA FILAHA & AGROFOOD and the National Agriculture Exhibition “Mosta Expo,” showcases her commitment to sharing knowledge and fostering innovation.

🌟Legacy and Future Contributions :

Djalila Boudemagh’s legacy lies in her dedication to education, research, and the advancement of science. Her contributions to the synthesis and application of materials and nanomaterials have paved the way for future innovations in health and environmental technologies. As a member of the Mediterranean Network Act for Health and the CATI “Technology and Innovation Support Center” at Ferhat Abbas University Setif 1, she continues to collaborate with international experts and institutions, driving forward research and development in her field.

🎓Publication 

Quantification, phytochemical evaluation, and identification of pomegranate yellow peel constituents using LC-MS/MS, the effect of the solvent extract on the antioxidant, in vitro anti-inflammatory, and antibacterial activities

Elaboration of hydroxyapatite nanoparticles and chitosan/hydroxyapatite composites: a present status

Isolation, characterization, antioxidant activity, and protein-precipitating capacity of the hydrolyzable tannin punicalagin from pomegranate yellow peel (Punica granatum)

Crystal structure analysis of the Mg2Si1-xSn x system having potential thermoelectric properties at high temperature

  • Authors  :Boudemagh, D., Fruchart, D., Haettel, R., … Toboła, J., Wolfers, P.z
  • Journal   :Solid State Phenomena
  • Year        :   2011